Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionStrs Ohio
Latest Disclosed Ownership12,600 shares
Latest Disclosed Value $ 830,466
Strs Ohio reports 2.44% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On April 24, 2026 - Strs Ohio filed a 13F-HR form disclosing ownership of 12,600 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $680,400 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 2, 2026 disclosing 12,300 shares of Cytokinetics, Incorporated. This represents a change in shares of 2.44% during the quarter. The current value of the position is $785,232 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F CYTOKINETICS COM_STK 23282W605 12,600 300 2.44 830 6.27 0.0033
2026-02-02 2025-12-31 13F CYTOKINETICS COM_STK 23282W605 12,300 1,700 16.04 782 34.19 0.0029
2025-10-30 2025-09-30 13F CYTOKINETICS COM_STK 23282W605 10,600 3,000 39.47 583 131.87 0.0021
2025-08-04 2025-06-30 13F CYTOKINETICS COM_STK 23282W605 7,600 -2,800 -26.92 251 -39.81 0.0009
2025-05-28 2025-03-31 13F CYTOKINETICS COM_STK 23282W605 10,400 0 0.00 418 -14.72 0.0018
2025-05-28 2024-12-31 13F CYTOKINETICS COM_STK 23282W605 10,400 -1,400 -11.86 489 -21.51 0.0019
2024-11-01 2024-09-30 13F CYTOKINETICS COM_STK 23282W605 11,800 -500 -4.07 623 -6.46 0.0024
2024-08-05 2024-06-30 13F CYTOKINETICS COM_STK 23282W605 12,300 2,400 24.24 666 0.0026
2024-05-13 2024-03-31 13F CYTOKINETICS COM_STK 23282W605 9,900 4,400 80.00 1 0.0028
2024-01-30 2023-12-31 13F CYTOKINETICS COM 23282W605 5,500 0 0.00 0 0.0019
2023-10-26 2023-09-30 13F/A-1 CYTOKINETICS COM 23282W605 5,500 0 0.00 0 0.0007
2023-10-26 2023-09-30 13F CYTOKINETICS COM 23282W605 5,500 0 0 0.0007
2023-07-31 2023-06-30 13F CYTOKINETICS COM 23282W605 5,500 1,200 27.91 0 0.0008
2023-08-02 2023-03-31 13F/A-2 CYTOKINETICS COM 23282W605 4,300 0 0.00 0 0.0007
2023-08-02 2023-03-31 13F/A-1 CYTOKINETICS COM 23282W605 4,300 0
2023-04-27 2023-03-31 13F CYTOKINETICS COM 23282W605 4,300 0 0 0.0008
2023-01-26 2022-12-31 13F CYTOKINETICS COM 23282W605 4,300 -4,500 -51.14 0 -100.00 0.0009
2022-10-27 2022-09-30 13F CYTOKINETICS COM 23282W605 8,800 1,900 27.54 426 57.20 0.0020
2022-07-25 2022-06-30 13F CYTOKINETICS COM 23282W605 6,900 6,400 1,280.00 271 1,405.56 0.0012
2022-04-21 2022-03-31 13F CYTOKINETICS COM 23282W605 500 0 0.00 18 -18.18 0.0001
2022-01-24 2021-12-31 13F CYTOKINETICS COM 23282W605 500 500 22 0.0001
2016-10-27 2016-09-30 13F CYTOKINETICS COM 23282W605 0 -64,900 -100.00 0 -100.00
2016-07-26 2016-06-30 13F CYTOKINETICS COM 23282W605 64,900 5,000 8.35 615 45.73 0.0027
2016-04-25 2016-03-31 13F/A-1 CYTOKINETICS COM 23282W605 59,900 0 0.00 422 -32.59 0.0019
2016-01-28 2015-12-31 13F CYTOKINETICS COM 23282W605 59,900 -32,600 -35.24 626 1.29 0.0028
2015-10-21 2015-09-30 13F CYTOKINETICS COM 23282W605 92,500 -11,900 -11.40 618 -11.84 0.0029
2015-08-04 2015-06-30 13F CYTOKINETICS COM 23282W605 104,400 45,800 78.16 701 76.57 0.0031
2015-04-27 2015-03-31 13F/A-1 CYTOKINETICS COM 23282W605 58,600 55,100 1,574.29 397 1,317.86 0.0018
2015-04-21 2015-03-31 13F CYTOKINETICS COM 23282W605 58,600 397
2015-01-23 2014-12-31 13F CYTOKINETICS COM 23282W605 3,500 0 0.00 28 133.33 0.0001
2014-10-29 2014-09-30 13F/A-1 CYTOKINETICS COM 23282W605 3,500 0 0.00 12 -29.41 0.0001
2014-10-20 2014-09-30 13F CYTOKINETICS COM 23282W605 3,500 12
2014-07-24 2014-06-30 13F CYTOKINETICS COM 23282W605 3,500 0 0.00 17 -48.48 0.0001
2014-04-28 2014-03-31 13F CYTOKINETICS COM 23282W605 3,500 -7,600 -68.47 33 -60.71 0.0001
2013-10-24 2013-09-30 13F CYTOKINETICS COM 23282W605 11,100 11,100 84 0.0004
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.